Eucure Biopharma
Beijing
About Eucure Biopharma
Eucure Biopharma is a global biotechnology company headquartered in Beijing, China. They are committed to the discovery and development of innovative immuno-oncology targeted antibodies which mainly focus on immune checkpoints. Several products have entered the CMC stage and has applied for clinical trial in 2019. Their mission is to develop antibody treatments to improve the survival rate of tumor patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $38.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2018)
- Website: eucure.comen
- Phone: 86-10-5631-5309
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Oncology, Pharmaceutical
Canonical: https://fsome.com/organization/eucure-biopharma-82513 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.